Leigh Farrell
Director/Board Member at PRO MEDICUS LIMITED
Net worth: 306 739 $ as of 30/04/2024
Leigh Farrell active positions
Companies | Position | Start | End |
---|---|---|---|
PRO MEDICUS LIMITED | Director/Board Member | 08/09/2017 | - |
Independent Dir/Board Member | 08/09/2017 | - | |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Corporate Officer/Principal | - | - |
Adned Pty Ltd. | Director/Board Member | - | - |
Chief Executive Officer | - | - | |
Ena Respiratory Pty Ltd.
Ena Respiratory Pty Ltd. BiotechnologyHealth Technology Ena Respiratory Pty Ltd. operates as a biotechnology company. It develops novel, synthetic innate immunomodulators for the prevention of respiratory viral and bacterial infections. The company is headquartered in Melbourne, Australia. | Director/Board Member | - | - |
DMTC Ltd. | Corporate Officer/Principal | - | - |
Career history of Leigh Farrell
Former positions of Leigh Farrell
Companies | Position | Start | End |
---|---|---|---|
Gene Shears Pty Ltd. | Chief Executive Officer | - | - |
d3 Medicine LLC
d3 Medicine LLC Pharmaceuticals: MajorHealth Technology d3 Medicine LLC develops drugs and medicines. It is strategic advisory company focused on developing medicines for use in indications including infectious diseases, oncology, and inflammation. The company was founded by Craig Rayner in 2012 and is headquartered in Parsippany, NJ. | Chairman | - | - |
Chief Operating Officer | - | - | |
GBS Venture Partners Pty Ltd.
GBS Venture Partners Pty Ltd. Investment ManagersFinance GBS Venture Partners Pty Ltd (GBS Venture Partners) is a venture capital firm founded in 1996 by Helen Brigitte Smith and Geoff E.D Brooke. The firm is headquartered in Melbourne. | Corporate Officer/Principal | - | - |
Aviragen Therapeutics, Inc.
Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections. Its product candidates include vapendavir, an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics; BTA074, a topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment for influenza A and B infections. The company was founded on November 8, 2012 and is headquartered in Alpharetta, GA. | Corporate Officer/Principal | - | - |
░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░ ░ ░░░░░░░ ░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Training of Leigh Farrell
Monash University | Doctorate Degree |
Statistics
International
Australia | 11 |
United States | 4 |
Operational
Corporate Officer/Principal | 6 |
Director/Board Member | 4 |
Chief Executive Officer | 2 |
Sectoral
Health Technology | 5 |
Commercial Services | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
PRO MEDICUS LIMITED | Health Services |
Private companies | 11 |
---|---|
Cortical Pty Ltd.
Cortical Pty Ltd. BiotechnologyHealth Technology Cortical Pty Ltd. discovers and develops medical drugs for the treatment of inflammatory and proliferative diseases. The company was founded in 2003 by Eric F. Morand and Magdy N. Iskander and is headquartered in Clayton, Australia. | Health Technology |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Commercial Services |
Johnson & Johnson Research Pty Ltd. | |
Certara USA, Inc.
Certara USA, Inc. Miscellaneous Commercial ServicesCommercial Services Certara USA, Inc. provides drug development consultancy solutions. It offers benefits of modeling and simulation, label optimization, pediatric drug development, orphan drug development, clinical trial outcomes databases, and therapeutic areas. The company was founded in 2008 and is headquartered in Princeton, NJ. | Commercial Services |
Aviragen Therapeutics, Inc.
Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections. Its product candidates include vapendavir, an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics; BTA074, a topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment for influenza A and B infections. The company was founded on November 8, 2012 and is headquartered in Alpharetta, GA. | Health Technology |
GBS Venture Partners Pty Ltd.
GBS Venture Partners Pty Ltd. Investment ManagersFinance GBS Venture Partners Pty Ltd (GBS Venture Partners) is a venture capital firm founded in 1996 by Helen Brigitte Smith and Geoff E.D Brooke. The firm is headquartered in Melbourne. | Finance |
Gene Shears Pty Ltd. | |
d3 Medicine LLC
d3 Medicine LLC Pharmaceuticals: MajorHealth Technology d3 Medicine LLC develops drugs and medicines. It is strategic advisory company focused on developing medicines for use in indications including infectious diseases, oncology, and inflammation. The company was founded by Craig Rayner in 2012 and is headquartered in Parsippany, NJ. | Health Technology |
Adned Pty Ltd. | |
Ena Respiratory Pty Ltd.
Ena Respiratory Pty Ltd. BiotechnologyHealth Technology Ena Respiratory Pty Ltd. operates as a biotechnology company. It develops novel, synthetic innate immunomodulators for the prevention of respiratory viral and bacterial infections. The company is headquartered in Melbourne, Australia. | Health Technology |
DMTC Ltd. |
- Stock Market
- Insiders
- Leigh Farrell
- Experience